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The evaluation focused on 
two categories of costs: direct 
costs and indirect costs. The 
direct costs are related to the 
expenditures made by the Go-
vernment and the patients in 
the year. They are different on 
the one hand to medical costs 
including expenditure on drugs, 
medical tests and imaging and 
on the other hand to non-me-
dical costs related to transport, 
accommodation and catering. 
Indirect costs are lost revenues 
due to work absenteeism due 
to morbidity and loss of income 
caused by the patient’s death 
before retirement. 
Six groups of tobacco-related 
diseases were selected from 
the list of 26 diseases identified 
by WHO, taking into account 
their importance in care statis-
tics in Senegal. These include 
lung cancer, laryngeal can-
cer, oral cavity cancer, chronic 
obstructive pulmonary disease 
(COPD), ischemic heart di-
sease and stroke. 
The data used come mainly 
from the survey of 14 public 
hospitals representative of the 
Senegal hospital card. Data 
were collected from a sample 
of 2001 patients treated and 
their carers during the year 
2017. Other sources of data 
are hospital records and hospi-
tal financial and accounting do-
cuments, WHO overall disease 
burden statistics, the Poverty 
Monitoring Survey in Senegal 
(ESPS 2011), and the Natio-
nal Statistics and Demography 
Survey Agency (ANDS). 
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INTRODUCTION 
The consumption of tobacco products provides tax revenues to governments. It also allows a part 
of the population to have a job in production factories and in the trade of these products. However, 
it kills more than seven million people worldwide each year. If the current trend of consumption of 
these products continues, the deaths that will be directly linked to it could double by 2030. More than 
80% of these deaths will occur in developing countries (WHO, 2013). In Senegal, as in the other 
countries of the Economic Community of West African States (ECOWAS), no evaluation is made of 
the costs of smoking to enable society to compare them with the benefits in terms of tax revenues 
and employment generated income. It is in order to provide these comparative elements and to 
enlighten political decision-making on tobacco that CRES conducted a research entitled «Costs of 
smoking in Senegal». This policy brief reports on the key findings of this research.
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Chart 1 shows that smoking costs FCFA 122 
billion to the Senegalese society in 2017. The 
income losses due to absenteeism of patients 
and their caregivers at work and those related to 
the death of patients before retirement amount 
to FCFA 48 billion. Direct costs are FCFA 74 bil-
lion, divided between direct medical costs (FCFA 
69 billion) and non-medical ones FCFA 5 billion). 
Chart 1 : The total cost attributable to smoking in 2017 (in billions of CFAF)
Chart 2 : Share of Direct Cost Attributable to Tobacco in Public Health Expenditures
	 A	significant	part	of	the	health	budget	used	to	cure	smoking-related	diseases
	 A	very	high	global	cost	attributable	tobacco
RESULTS  
If we consider the part of the direct costs of 
smoking supported by the Government, 51 bil-
lion FCFA, we notice that it represents a large 
proportion of the national budget allotted to the 
health sector. Chart 2 shows that 17% of this bud-
get are used to treat patients with non-communi-
cable diseases caused by tobacco products.     
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	 Lower	costs	for	cancers
	 Costs	well	above	the	contributions	of	the	tobacco	industry
Chart 3 : Share of cost attributable to tobacco by disease
When we examine the distribution of the costs 
attributable to tobacco among the six selected 
diseases, it appears that the largest share is due 
to OCBP (Chart 2). Their treatment represents 
68% of this total cost. This predominance is due 
to their higher prevalence compared to other di-
seases. Ischemic heart disease is the second 
group of tobacco-related diseases, constituting 
19% of the total cost. Cancers have the lowest 
share of the total cost of smoking. Lung cancer, 
of which tobacco is the main risk factor, consti-
tutes only 4% of the total cost. Patients suffering 
from this cancer are usually diagnosed very late. 
The consumption of tobacco products contributes to the economy through the tax revenues collec-
ted, the payrolls distributed and the commercial benefits derived from their commercialization. If we 
stick to the first two sources of revenue, the government tax revenue from tobacco products was 20 
billion FCFA and the payrolls distributed by the tobacco industry 4 billion FCFA. Thus, smoking cost 
CFA 123 billion to the Senegalese society in 2017 while it brings only 24 billion FCFA francs. If the 
total cost is broken down by category of economic agents, households bear a larger share of the to-
tal costs of smoking than the government. They lose 71 billion FCFA annually, while the government 
loses only 51 billion FCFA. 
 	 Recommendations	
The results of this research make it possible to formulate three main recommendations.
1) Senegalese government must regularly increase taxes on tobacco products in order to 
discourage their consumption and collect tax revenues at a level that makes it possible to 
offset a large part of the costs.  
2) The government must enforce non-tax measures such as the ban on smoking in public 
places, the ban on advertising on tobacco products, the posting of health warnings on 
cigarette packets. 
3) Civil society organizations, as well ascompanies need to educate people and workers about 
the dangers of tobacco use.
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The Research Center for International Development (IDRC) has funded the 
Consortium for Economic and Social Research (CRES) to conduct an action 
research on the taxation of tobacco products. This phase is entitled “Tax solutions 
for an optimal reduction of smoking in West Africa”.  One of the objectives of 
this phase was to evaluate the costs of tobacco-related diseases in Senegal.
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Graphic 4 : Annual cost and income from tobacco consumption in Senegal (in billions of FCFA)
